Related by context. Frequent words. (Click for all words.) 53 Stock Repurchase Plan 51 Share Repurchase Plan 49 Nasdaq Hearings Panel 49 Plavix patent 49 FDA approvable letter 48 NASDAQ Listing Rules 48 Annual Stockholder Meeting 47 SUAI 47 Special Shareholder Meeting 47 YS Mining 47 Stockholders Meeting 47 See BioWorld Today 46 Protalix BioTherapeutics 46 Shelf Registration Statement 46 DepoMed 46 Enpath 46 Company Nasdaq PRGO 46 CreXus 46 Subsequent Offering 46 Proposed Settlement 45 DDUP 45 Share Repurchase Program 45 CVTX 45 recission 45 Repurchase Program 45 Angiox 45 reexamination proceedings 45 Amended Agreement 45 Stockholder Rights Plan 45 #/shr 44 Printcafe 44 Restated Certificate 44 Par Pharmaceuticals 44 % Convertible Subordinated 44 Biologics License Application 44 EVVV 44 Marketing Authorization Application MAA 44 ATryn ® 44 PLAVIX R 44 Biologics License Application BLA 44 Tolmar 44 share repurchase authorization 44 IsoTis 44 supplemental Biologics License Application 44 stockholder approval 44 MNTA 43 CV Therapeutics 43 Restated Articles 43 pediatric exclusivity 43 Celeritek 43 Complete Response letter 43 Files Annual Report 43 grossly undervalues 43 Convertible Senior Subordinated 43 C Convertible Preferred 43 sBLA 43 Epimmune 43 Oxandrin 43 solicit proxies 43 ZGEN 43 delisting proceedings 43 AUXL 43 convertible debenture financing 43 Combination Agreement 43 Stockholders Approve Merger 43 Rotarix R 43 accounts receivable securitization 43 NASDAQ CGNX 43 Interpharm 43 Nasdaq SmallCap 43 Senior Subordinated Convertible Notes 43 VNDA 43 NYSE BRL 43 #Q filing 43 Iridex 43 Certara 43 Repurchasing 42 Plenaxis R 42 Caremark stockholders 42 AnorMed 42 Actual increments 42 COMFORCE 42 confirmatory due diligence 42 Citizen Petition 42 Mylan Labs 42 Advanced Analogic 42 stockholder approvals 42 Annual Meeting Date 42 CLDA 42 Termination Date 42 Penmont 42 Nortel remedial 42 Approvable Letter 42 CFO resigns 42 tender offer 42 NYSE MYL 42 Including discontinued operations 42 Announces Stockholder Approval 42 MDCO 42 repurchase 42 Shareholder Approval